Funding to deliver the Accelerator to improve outcomes for diabetes and cardiovascular disease
Medical Research Future Fund – Preventive and Public Health Research Initiative – 2020 Targeted Translation Research Accelerator Grant Opportunity
What do you get?
The maximum grant amount is $47 million.
Who is this for?
Eligible organisations seeking to deliver the Accelerator.
Overview
The 2020 Targeted Translation Research Accelerator Grant Opportunity was announced as part of the Medical Research Future Fund and is an Initiative under the Preventive and Public Health Research Initiative.
The objective of the grant opportunity is to support the development of novel preventive, diagnostic and therapeutic approaches and products for diabetes and cardiovascular disease.
To achieve this objective an organisation will be funded to deliver the Accelerator as a comprehensive package of activities to improve outcomes for diabetes and cardiovascular disease.
Governance for the implementation of this project by the organisation will be provided by a board of experts appointed by the Minister for Health.
The successful independent organisation will be responsible for ensuring that the Accelerator:
- establishes through competitive processes two research centres, one for diabetes and one for cardiovascular disease to accelerate therapies for the prevention, early detection and treatment of disease related complications
- supports through competitive processes research projects on the potential common pathways interactions, and complexities for patients experiencing two or more of the following: Type 1 diabetes; Type 2 diabetes; and cardiovascular disease
- targets investment and related support through partnership projects to progress promising drug and device development projects, with a focus on promoting commercialisation of novel therapeutics and devices for diabetes and cardiovascular disease
- sources, nurtures and invests in early stage therapeutic research targets to transform diagnostic and therapeutic care for people with diabetes
- commissions and conducts research to support the health and commercial sectors to deliver transformations in diabetes and cardiovascular disease.
The expected outcome of the research funded through partnership projects with the independent organisation selected under the grant opportunity is to improve knowledge and its translation into practice in order to reduce the burden of diabetes and cardiovascular disease.
Applicants are encouraged to seek strategic partnerships with organisations whose decisions and actions affect Australians’ health, health policy and health care delivery in ways that improve the health of Australians. Organisations that are capable of implementing policy and service delivery and would normally not be able to access funding through most MRFF funding mechanisms are highly valued as partners.
For more information on partnerships in this grant opportunity please see sections 1.4, 3 and 6.2 of the grant opportunity guidelines.
Eligibility
What are the eligibility criteria?
To be eligible you must:
- have an Australian Business Number (ABN)
- be incorporated in Australia
and in accordance with s20 and s24 of the Medical Research Future Fund Act 2015, be one of the following entities:
- a medical research institute
- a university
- a corporate Commonwealth entity
- a corporation (including businesses and not for profits)
- a state or territory government entity.
Joint applications are encouraged, provided you have a lead organisation who is the main driver of the project and is eligible to apply.
We cannot waive the eligibility criteria under any circumstances.
You are not eligible to apply if you are:
- an individual
- a partnership
- an unincorporated association
- any organisation not included in section 3.1 of the grant opportunity guidelines
- a trust (however, an incorporated trustee may apply on behalf of a trust)
- a non-corporate Commonwealth entity.
Applying
How do you apply?
The 2020 Targeted Translation Research Accelerator Grant Opportunity is currently closed to applications.
We assess your application against the eligibility criteria and then against the assessment criteria. Only eligible applications will proceed to the assessment stage.
We refer your application to an independent committee of national and international experts.
The Program Delegate (who is an Australian Government official who has been authorised to make decisions) will make the final decision.
We will only award funding to an application that scores satisfactorily against all criteria.
- Assessment criterion 1 - Project impact (40% weighting)
- Assessment criterion 2 - Project methodology (30% weighting)
- Assessment criterion 3 - Capacity, capability and resources to deliver the project (30% weighting)
- Assessment criterion 4 - Overall value and risk of the project (non-weighted)
Scoring information for all assessment criteria can be found at Appendix C and Appendix D of the grant opportunity guidelines.
If your application is successful, you will receive a written offer. If you are unsuccessful, we will notify you in writing and give you the chance to discuss the outcome with us.
Successful applicants must enter into a grant agreement with the Commonwealth. The grant agreement will specify the reporting requirements, payment schedule and milestones necessary to receive payments.
We will make payments according to an agreed schedule set out in the grant agreement. Payments are subject to satisfactory progress on the project.
Payments will be made by direct credit into a nominated bank account.
Need help?
Let us answer your question via phone, email or live chat. And if we can't help, we'll put you in touch with someone who can.
- Phone:
-
Open Hours:
Monday – Friday, 8am – 8pm across Australia
- Website:
Key documents
Board and CEO letter
docx · 0.03 MBMRFF grant management resources
Reporting templates are available from the MRFF grants management webpage. The page also provides other resources for MRFF grant administration, including current policies and relevant forms and templates.
We use cookies to give you a better experience on our website. Learn more about how we use cookies and how you can select your preferences.